Sionna Therapeutics, Inc. Common Stock SION Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$85.57M-29.0% | -$75.27M-22.0% | -$70.68M— | -$75.84M— | -$66.32M— | ||
| $506K-30.3% | $511K-30.3% | $526K— | $626K— | $726K— | ||
| $16.53M+221% | $12.07M+225% | $9.3M— | $7.02M— | $5.16M— | ||
| -$71.85M-28.5% | -$66.3M-25.6% | -$61.45M— | -$63.91M— | -$55.9M— | ||
| $291K+158% | $377K+1,296% | $200K— | $113K— | $113K— | ||
| —— | —— | —— | —— | —— | ||
| $5.53M— | $206.02M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$72.14M-28.8% | -$66.67M-26.2% | -$61.65M— | -$64.02M— | -$56.01M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sionna Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.